Establishment Labs Holdings Inc. (ESTA)
NASDAQ: ESTAHealth CareIndustrial SpecialtiesUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 63.85 0.00%
ESTA stock chart
Technical analysisKey statistics
All statistics- Market cap
- $1.90B
- Forward P/E
- 1,064.17
- EPS (TTM)
- -$1.30
- Dividend yield
- None
- 52-week range
- 38.38 – 97.59
- Day range
- 63.68 – 65.97
- Volume / Avg
- 438.39K / 426.60K
- Beta
- —
- Shares outstanding
- 29.80M
- Next earnings
- Nov 4, 2026
52-week range
ESTA stock today
Shares of Establishment Labs (ESTA) finished lower on Oct 7 at $63.85, a drop of 2.21% or $1.44 per share, versus the S&P 500's 0.22% decline. Shares are 34.6% below their 52-week high of $97.59, set on Aug 3, 2026 and 66.4% above the 52-week low of $38.38, in the middle of the past year's range. ESTA is down 12.4% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 57.8%.
Establishment Labs has posted a net loss over the last twelve months (EPS of -$1.30), so its P/E ratio is not meaningful. Establishment Labs's next earnings report is expected on Nov 4, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Establishment Labs
Company profileEstablishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders.
- Sector
- Health Care
- Industry
- Industrial Specialties
- CEO
- Mr. Fillipo Peter Caldini
- Headquarters
- Austin, TX
- Employees
- 1,004
- IPO year
- 2018
- Website
- establishmentlabs.com
Analyst forecast
ForecastConsensus (9 analysts)
strong_buy
Avg. price target
$102.44+60.44%
- Strong buy 2
- Buy 7
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Nov 4, 2026
- EPS estimate
- $-0.32
Establishment Labs peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| DSGRDistribution Solutions Group Inc. | 35.07 | +0.06% | $1.62B | vs ESTA |
| TRSTriMas Corporation | 38.25 | -1.85% | $1.37B | vs ESTA |
| XPELXPEL Inc. | 44.32 | -1.84% | $1.22B | vs ESTA |
| CDRECadre Holdings Inc. | 24.97 | -2.08% | $1.07B | vs ESTA |
| ENOVEnovis Corporation | 17.61 | -3.24% | $1.02B | vs ESTA |
| PIIPolaris Inc. | 52.79 | 0.00% | $3.00B | vs ESTA |
| WLFCWillis Lease Finance Corporation | 41.21 | -3.83% | $871.35M | vs ESTA |
| ADSEADS-TEC ENERGY PLC | 9.69 | -1.72% | $728.55M | vs ESTA |
Indexes, lists and sector
Establishment Labs stock FAQ
What is Establishment Labs's stock price today?
ESTA last traded at $63.85 as of Oct 7, 4:00 PM EDT, down 2.21% on the day. Prices are delayed at least 15 minutes.
When is Establishment Labs's next earnings date?
Establishment Labs is expected to report earnings on Wednesday, November 4, 2026. Analysts expect EPS of $-0.32.
Who is Establishment Labs's CEO?
Mr. Fillipo Peter Caldini is the chief executive officer of Establishment Labs Holdings Inc., which has about 1,004 employees.
What is the ESTA 52-week high?
The 52-week high for ESTA is $97.59 and the 52-week low is $38.38. The stock is currently 34.6% below its high.